This June 2026 notification signals a maturing pharmacovigilance framework. For stakeholders from large-scale manufacturers and CMOs to frontline healthcare providers, the message is clear: scientific justification is the only path to market survival. This article breaks down the ban and explores the strategic shifts necessary for industry compliance.

the blog provides idea about the pharmaceutica industry, while saving lives, also leaves a heavy ecological footprint through high water usage, energy demands, plastic packaging, chemical waste, and global supply chains. This blog explores how sustainability is transforming pharma, from green chemistry and renewable energy to eco-friendly packaging innovations like glass jars, aluminum caps, and paper-based blisters. It reviews regulatory frameworks in India and globally, whi

Explore high-impact opportunities as branded and blockbuster drugs lose patent protection in India between 2025-2027. Gain insights into...